Nadine Shehab, PharmD, MPH

Nadine Shehab is a health scientist with 15 years’ experience in adverse drug event (ADE) surveillance as well as other medication and patient safety issues. Nadine has experience in a wide array of public and private sector partnerships at national, state, and local levels; internal and external agency engagement; public health policy; health informatics domains; and public health response activities (2005 Hurricane Katrina, 2009 H1N1 Pandemic, 2014-2015 Ebola outbreak). Prior to Lantana, she was a senior scientist with the Centers for Disease Control and Prevention’s (CDC) Division of Healthcare Quality Promotion (DHQP), providing leadership in national public health surveillance for healthcare-related harm, identifying and implementing national policy directions for high-priority CDC medication safety issues, and representing CDC’s public health priorities for medication safety in nationally recognized healthcare quality measures, standards, and guidelines and to policymakers and regulators.

At Lantana, Nadine uses her expertise in public health and pharmaceutical and epidemiological sciences to lead and support multiple projects related to healthcare delivery, quality reporting, and public health. She also identifies opportunities to advance medication and patient safety and improve healthcare delivery through electronic data exchange.